QUARTERLY FINANCIAL DATA

12 Months Ended

Dec. 31, 2016

Quarterly Financial Data [Abstract]

QUARTERLY FINANCIAL DATA

QUARTERLY FINANCIAL DATA

Selected quarterly financial data for the years ended December 31, 2016 and 2015 is as follows:

	For the Year Ended December 31, 2016
	First Quarter (Unaudited)			Second Quarter (Unaudited)			Third Quarter (Unaudited)			Fourth Quarter (Unaudited)
Consolidated Statements of Operations and Comprehensive Income / Loss Data:
Net revenues	$	129,000		$	175,206		$	126,706		$	207,101
Cost of revenues	97,777			104,962			91,141			119,946
Operating income	7,763			43,891			8,384			51,551
(Loss) / income from continuing operations	(40,694		)	(141,249		)	(19,823		)	21,169
Net (loss) / income	(40,694		)	(141,249		)	(19,823		)	21,169
Net (loss) / income attributable to CME Ltd.	(40,435		)	(141,317		)	(19,627		)	21,088
Net (loss) / income per share:
Basic EPS	$	(0.31	)	$	(0.98	)	$	(0.14	)	$	0.07
Effect of dilutive securities	—			—			—			(0.01		)
Diluted EPS	$	(0.31	)	$	(0.98	)	$	(0.14	)	$	0.06

	For the Year Ended December 31, 2015
	First Quarter (Unaudited)			Second Quarter (Unaudited)			Third Quarter (Unaudited)			Fourth Quarter (Unaudited)
Consolidated Statements of Operations and Comprehensive Income / Loss Data:
Net revenues	$	126,133		$	166,834		$	117,322		$	195,552
Cost of revenues	98,828			101,229			85,832			116,654
Operating (loss) / income	(17,239		)	36,441			28,853			46,528
(Loss) / income from continuing operations	(70,243		)	(11,669		)	(21,510		)	1,137
(Loss) / income from discontinued operations, net of tax	(3,288		)	2,684			(265		)	(12,418		)
Net loss	(73,531		)	(8,985		)	(21,775		)	(11,281		)
Net loss attributable to CME Ltd.	(73,274		)	(8,678		)	(21,522		)	(11,427		)
Net loss per share:
Basic EPS	$	(0.53	)	$	(0.09	)	$	(0.18	)	$	(0.11	)
Effect of dilutive securities	—			—			—			—
Diluted EPS	$	(0.53	)	$	(0.09	)	$	(0.18	)	$	(0.11	)